• OUR COMPANY

    • About AIP
    • Leadership
  • OUR SCIENCE

    • Pipeline
    • Rare Pediatric Diseases
    • HER2+ Breast Cancer
  • CAREERS

  • PARTNERSHIPS

  • BLOG

  • CONTACT US

  • More

    Use tab to navigate through the menu items.
    Our Response to COVID-19
    Daniel Gigante
    • Apr 2, 2020
    • 1 min

    Our Response to COVID-19

    Our team is developing and clinically validating Septane, a precision medicine that can impact the treatment of COVID-19. We are particularl
    0 comments
    • LinkedIn Social Icon
    • Facebook Social Icon
    • Twitter Social Icon
    • YouTube Social  Icon

    Contact: 561-757-8666

    © 2020 Advanced Innovative Partners, Inc., U.S.A.

    Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to AIP Inc., its subsidiaries or affiliates. No use of any AIP trademark, trade name, or trade dress in this site may be made without the prior written authorization of AIP Inc., except to identify the product or services of the company.